These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8842755)

  • 21. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.
    Yiannopoulos G; Pastromas V; Antonopoulos I; Katsiberis G; Kalliolias G; Liossis SN; Andonopoulos AP
    Rheumatol Int; 2007 Feb; 27(4):357-61. PubMed ID: 17021713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.
    Nannini C; West CP; Erwin PJ; Matteson EL
    Arthritis Res Ther; 2008; 10(5):R124. PubMed ID: 18937831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
    Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G;
    Arthritis Res Ther; 2018 Jan; 20(1):17. PubMed ID: 29382380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of monthly cyclophosphamide pulses on skin sclerosis in systemic sclerosis.
    Khader A; Valiaveetil B; Nalini SD; George B; Sasidharanpillai S; Nazeer MMA; Manikath N
    Indian J Dermatol Venereol Leprol; 2021; 87(5):728-731. PubMed ID: 34379952
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?
    Takizawa H; Ito K
    Intern Med; 1997 Jul; 36(7):448-9. PubMed ID: 9240490
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis.
    Takahashi T; Asano Y; Sunaga R; Ichimura Y; Taniguchi T; Yamamoto M; Tamaki Z; Takekoshi T; Mitsui H; Sugaya M; Ohse T; Sato S
    J Dermatol; 2014 Jun; 41(6):533-5. PubMed ID: 24814462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of ischemic colitis and scleroderma renal crisis following methylprednisolone pulse therapy for progressive systemic sclerosis.
    Yamanishi Y; Yamana S; Ishioka S; Yamakido M
    Intern Med; 1996 Jul; 35(7):583-6. PubMed ID: 8842768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.
    Ostojic P; Damjanov N
    Clin Rheumatol; 2006 Nov; 25(6):819-21. PubMed ID: 16440134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis.
    Takahashi T; Asano Y; Akamata K; Aozasa N; Taniguchi T; Noda S; Masui Y; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2013 Sep; 23(5):884-90. PubMed ID: 22972016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of mycophenolate associated with methotrexate as a maintenance treatment for systemic sclerosis-associated interstitial lung disease].
    Gonzalez-Nieto JA; Martin-Suarez IJ; Gil-Muñoz FL
    Arch Bronconeumol; 2011 Nov; 47(11):575. PubMed ID: 21821334
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis.
    Broad K; Pope JE
    Med Sci Monit; 2010 Sep; 16(9):RA187-90. PubMed ID: 20802426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Mittal G; Udwadia Z; Joshi VR
    J Rheumatol; 2003 May; 30(5):1121-2; author reply 1122. PubMed ID: 12734923
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis.
    Scheja A; Hesselstrand R; Wildt M; Akesson A
    Rheumatology (Oxford); 2007 Dec; 46(12):1862-3. PubMed ID: 17971385
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolated Ileocolonic Histoplasmosis in an HIV-Negative Patient.
    Zhang B; Martin VK; Motamedi N; Shao L
    Dig Dis Sci; 2017 Aug; 62(8):2201-2202. PubMed ID: 28547647
    [No Abstract]   [Full Text] [Related]  

  • 37. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.
    Saketkoo LA; Espinoza LR
    Arch Intern Med; 2008 Aug; 168(15):1718-9. PubMed ID: 18695091
    [No Abstract]   [Full Text] [Related]  

  • 38. The need for nursing instruction in patients receiving steroid pulse therapy for the treatment of autoimmune diseases and the effect of instruction on patient knowledge.
    Pai YC
    BMC Musculoskelet Disord; 2010 Sep; 11():217. PubMed ID: 20858234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interstitial pneumonia treated with intermittent cyclophosphamide pulse therapy].
    Harada T; Takayama K; Kimotsuki K; Hidaka K; Miyazaki H; Kuwano K; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1221-6. PubMed ID: 8976077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.
    Majewski S; Skopińska M; Błaszczyk M; Ryba M; Grieb P; Chorzelski T; Jabłońska S
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):33-4. PubMed ID: 7503631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.